Multiple Sclerosis News TodayMS News Notes: Dalfampridine, Neural Sleeve, Vitamin D

Unraveling the Complexities of MS: Dalfampridine Side Effects, Neural Sleeve Innovation, and the Vitamin D Connection

This review from columnist and MS patient Ed Tobias looks into three distinct facets of multiple sclerosis (MS) management and research: the real-world side effects of dalfampridine, the innovative Neural Sleeve, and the correlation between vitamin D levels and cognitive function in MS patients. These findings underscore the multifaceted nature of MS and highlight the need for personalized, comprehensive care strategies.

Key Points

• Dalfampridine, also known as the “walking drug,” may cause side effects such as urinary tract infection, dizziness, and MS worsening. Unreported adverse events like spinal cord injury were also identified.
• The Neural Sleeve, an AI-powered bionic clothing product, has been recognized as a Time ‘best invention.’ It aids walking in MS patients and others with foot drop.
• A study found that low vitamin D levels in the blood are associated with poorer cognition and greater disability in MS patients. More than 39% of the patients in the study were found to be vitamin D deficient.

According to the National MS Society, nearly 1 million people are living with MS in the United States.

More on MS